News

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment
Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...
PMLive1h
EC approves argenx’s subcutaneous Vyvgart for rare autoimmune disease CIPD
The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) subcutaneous (SC) injection to treat chronic ...
GlobalData on MSN2d
EC approves argenx’s efgartigimod alfa for CIDP treatment
The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous ...
Restoring mobility: Rare autoimmune disease successfully treated with CAR T-cell therapy
A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...
body+soul3d
Swimming legend Michael Klim on chronic health condition: 'I didn’t act fast enough'
The Australian swimming legend and triple Olympian opens up about finding hope and courage in the face of a chronic health ...
The Pharma Letter1d
European approval for argenx expands autoimmune footprint
European biotech argenx (Euronext: ARGX) has secured European Commission approval for Vyvgart (efgartigimod alfa) in chronic ...
News Medical on MSN6d
First Use of CAR T-Cell Therapy for Autoimmune Neuropathy
A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...
pharmaphorum1d
FDA clears Argenx’ Vyvgart Hytrulo for rare disease CIDP
Argenx has a second FDA approval for FcRn inhibitor Vyvgart Hytrulo, adding new indication rare autoimmune disease CIDP. Skip to main content Friday 20 June 2025 . BlueSky linkedin youtube rss ...
PharmiWeb3h
Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney transplant recipientsRiliprubart was also designated orphan drug ...
Stocktwits on MSN4d
Argenx Gets European Commission Approval For Drug To Treat Rare Autoimmune Disease, But Stock Fails To Garner Retail Attention
Nasdaq-listed shares of argenx SE (ARGX) rose 2% by Friday afternoon after the company announced that the European Commission ...
Australian swimming legend Michael Klim opens up on devastating battle with rare autoimmune disorder and symptoms he wishes he hadn't ignored
Michael Klim has revealed details about his five-year battle with a rare autoimmune disorder which left him unable to walk - ...